MoneyWorks4Me

Ajanta Pharma informs about board meeting

13 Jan 2017 Evaluate

Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on January 24, 2017, to consider, approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the third quarter ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..